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Abstract
Early life is an important window of opportunity to improve health across the full lifecycle. An accumulating body of evi-
dence suggests that exposure to adverse stressors during early life leads to developmental adaptations, which subsequently 
affect disease risk in later life. Also, geographical, socio-economic, and ethnic differences are related to health inequalities 
from early life onwards. To address these important public health challenges, many European pregnancy and childhood 
cohorts have been established over the last 30 years. The enormous wealth of data of these cohorts has led to important 
new biological insights and important impact for health from early life onwards. The impact of these cohorts and their data 
could be further increased by combining data from different cohorts. Combining data will lead to the possibility of identi-
fying smaller effect estimates, and the opportunity to better identify risk groups and risk factors leading to disease across 
the lifecycle across countries. Also, it enables research on better causal understanding and modelling of life course health 
trajectories. The EU Child Cohort Network, established by the Horizon2020-funded LifeCycle Project, brings together 
nineteen pregnancy and childhood cohorts, together including more than 250,000 children and their parents. A large set of 
variables has been harmonised and standardized across these cohorts. The harmonized data are kept within each institution 
and can be accessed by external researchers through a shared federated data analysis platform using the R-based platform 
DataSHIELD, which takes relevant national and international data regulations into account. The EU Child Cohort Network 
has an open character. All protocols for data harmonization and setting up the data analysis platform are available online. The 
EU Child Cohort Network creates great opportunities for researchers to use data from different cohorts, during and beyond 
the LifeCycle Project duration. It also provides a novel model for collaborative research in large research infrastructures 
with individual-level data. The LifeCycle Project will translate results from research using the EU Child Cohort Network 
into recommendations for targeted prevention strategies to improve health trajectories for current and future generations by 
optimizing their earliest phases of life.
Keywords Consortium · Birth cohorts · Exposome · Life course · Non-communicable diseases
Rationale
Early life seems to be an important window of opportunity 
to improve health across the full lifecycle. An accumulating 
body of evidence suggests that exposure to adverse stressors 
during early life leads to developmental adaptations, which 
subsequently affect disease risk in later life [1]. Moreover, 
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geographical, socio-economic, and ethnic differences are 
related to health inequalities from early life onwards [1]. 
These research findings suggest that optimizing early-life 
conditions has the yet unfulfilled potential to improve life 
course health trajectories for individuals themselves and 
also for their offspring through transgenerational effects [2]. 
A better understanding of the causality, pathways and life 
course health trajectories explaining associations of early-
life stressors with later life disease is urgently needed to 
translate results from observational studies into population-
health prevention strategies.
Many European pregnancy and childhood cohorts have 
been established over the last years to assess the associa-
tions of early life with health across the lifecycle [3]. These 
cohorts are invaluable resources to obtain insight into soci-
etal, environmental, lifestyle and nutrition related deter-
minants that may influence the onset and evolution of risk 
factors and diseases in later life. Cohort studies that started 
during pregnancy or early childhood provide the unique 
opportunity to study the potential for early-life interventions 
on factors that cannot be easily studied in experimental set-
tings, such as socio-economic, migration, urban environment 
and lifestyle related determinants. Data from cohort studies 
can also be used for advanced analytical approaches such as 
sibling analyses and Mendelian randomization to assess cau-
sality of observed associations [4].
The impact of these cohorts and their data could be 
strongly increased by combining data from different cohorts. 
Combining data will lead to larger numbers and the oppor-
tunity to better identify risk groups and risk factors leading 
to disease across the lifecycle [3]. Also, it enables research 
for a better causal understanding and modelling of life 
course health trajectories. The enormous wealth of high-
quality prospective cohort studies enables collaboration at 
individual participant data level. Meta-analyzing individual 
participant data has the advantage that it can identify smaller 
effect estimates, specific subgroups, and mediator effects 
and, maybe most importantly, capitalizes on existing pub-
lished and unpublished data. Results from well-performed 
individual participant data meta-analyses suffer less from 
publication bias than meta-analyses based on published 
data. Multiple individual participant data meta-analyses on 
environmental exposures, lifestyle related and (epi)genetic 
associations have already been published as part of birth 
cohort collaborations [5–22].
The LifeCycle Project is a Horizon 2020-funded 
(2017–2022) international project. The general objective of 
the LifeCycle Project is to bring together pregnancy and 
childhood cohort studies into a new, open and sustainable 
EU Child Cohort Network, to use this network for identifica-
tion of novel markers of early-life stressors affecting health 
trajectories throughout the life course, and to translate find-
ings into policy recommendations for targeted prevention 
strategies. The overall concepts, design and future perspec-
tives are described in this paper. The logos of the LifeCycle 
Project are given in Fig. 1.
The EU Child Cohort Network
The EU Child Cohort Network, the main deliverable of the 
LifeCycle Project, brings together nineteen pregnancy and 
childhood cohorts. Together, they include more than 250,000 
children and their parents (Fig. 2; Table 1). Recruitment to 
the cohorts of the EU Child Cohort Network began prior 
to and during pregnancy, as well as in childhood; together, 
the follow-up of these cohorts span the full life course and 
contain detailed phenotypic information and biological sam-
ples. The research potential of the EU Child Cohort Network 
is summarized in Table 2. The EU Child Cohort Network 
should be operational mid-2020. This network is open for 
other partners with population-based cohorts that started 
in early life and will be sustainable after the duration of 
the Horizon 2020 funded LifeCycle Project. The EU Child 
Cohort Network could contribute to future collaborations 
between different cohorts.
The LifeCycle Project and its EU Child Cohort Network 
do not stand on their own. By building on and collaborating 
with existing initiatives, we will create new synergies and 
form the basis of future initiatives. These synergies bring 
together principal investigators and their expertise of several 
international collaborations. These initiatives include:
• Cohort collaboration and data sharing platforms: 
BioSHaRe [23], CHICOS [24], DataSHIELD [25], 
DynaHEALTH [26], EarlyNutrition [27], ENRIECO 
[28], HELIX [29, 30], InterConnect [31] and NutriMen-
the [32] (all EU-FP6, FP7 projects or Horizon2020).
• Genetic and epigenetic collaborations: Early Growth & 
Longitudinal Epidemiology (EAGLE), Early Growth 
Genetics (EGG) [33], Pregnancy And Childhood Epige-
netics (PACE) [34] (no specific funds for the collabora-
tion).
Fig. 1  Logo’s of the LifeCycle Project and EU Child Cohort Network
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• E-Learning: Early Nutrition Academy [35] (EU-FP7 pro-
ject).
Data harmonisation
The LifeCycle Project has developed a harmonized set of 
variables in each cohort necessary to perform multi-cohort 
analyses on different research questions. The harmonization 
work is performed by a data-harmonization group with repre-
sentatives from each partner or cohort. Based on the primary 
research focus in the LifeCycle Project, a priority list of varia-
bles has been developed for harmonisation. The cohort studies 
participating in the EU Child Cohort Network will be further 
enriched with novel harmonized integrated data on early-life 
stressors related to socio-economic, migration, urban envi-
ronment and lifestyle determinants, based on data availabil-
ity within the cohorts and external data from registries [36]. 
Integrated data will also be used to construct a novel holistic 
‘dynamic early-life exposome’ model, which will encompass 
many human environmental exposures during various stages 
of early life [37–40]. The harmonized variables relate to the 
main research hypotheses (Fig. 3), and include:
• Main exposures: Socioeconomic, migration, urban environ-
ment, lifestyle and nutrition related factors, genome-wide 
association screen;
• Main mediators: Epigenetics, metabolomics, allergy, brain 
development;
• Main outcomes: Cardio-metabolic (body mass index 
(BMI), body composition, blood pressure, cardiac structure 
and function, lipids, insulin, glucose); respiratory (allergy, 
wheezing, infections, lung function, asthma), mental 
(behaviour, cognition, education, ASD, ADHD, anxiety, 
depression);
The availability of these data in different cohorts is given 
in Table 1.
Fig. 2  LifeCycle Project core cohorts that established the EU Child Cohort Network
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Federated data analysis approach
Analyses in the EU Child Cohort will be predominantly 
using DataSHIELD, developed as part of the EU-FP7 
BioSHaRe Project [23, 25]. This is a safe and robust data 
analysis platform to perform joint multisite individual par-
ticipant data meta-analyses, without physically transferring 
data (Fig. 4). DataSHIELD enables connections between 
local servers to analyze harmonized data located at differ-
ent institutes. The major advantage of this approach is that 
the data from the different institutes, which together form 
the EU Child Cohort Network, are accessible for different 
researchers from various sites whilst they remain at the 
local sites.
Fair principles
The EU Child Cohort Network data management and 
access are based on the following key principles:
• Full compliance with best practice in data privacy and 
security;
• Use of coded data with appropriate institutional and 
participant consent;
• Use of privacy enhancing technologies such as filters;
• Use of policies that enable greater use of data in research;
• Approval of all procedures, policies and methods by 
the relevant local authorities.
Management of and access to all data is primarily the 
responsibility of each institution. The FAIR (findable, 
accessible, interoperable, reusable) principles are taken 
into account for the general data management approach.
Findable
The LifeCycle Project has revitalized the existing www.
birth cohor ts.net website. This website gives an overview of 
pregnancy and birth cohorts and the data available in these 
cohorts. Specific details of variables included in the EU 
child cohort network and their availability in the cohorts 
are presented in the open access EU Child Cohort Network 
Variable Catalogue. The catalogue was built using the 
MOLGENIS software platform for scientific data extend-
ing on BBMRI-ERIC directory of biobanks [41, 42]. It also 
documents how each cohort has harmonized these variables, 
including information about the source variables used by the 
cohorts. No actual data are given in the online catalogue. All 
relevant websites and their contents are presented in Table 3.
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Table 2  Potential of the 
LifeCycle Project-EU Child 
Cohort Network
Collaboration between prospective pregnancy/child cohort studies offers the opportunities to 1
Perform analyses in over 250,000 children and their parents
Harmonize methods for data collection, biobanks, management, and analyses
Perform analyses on published and unpublished data which limits publication bias
Perform individual participant data meta-analyses with better statistical precision
Stratify groups by geographical area or sex
Compare determinants and outcomes between European populations
Examine consequences of small variations in determinants from early life onwards
Identify variations in geography and time periods for specific associations
Infer causality from observed associations by advanced analytical approaches
Enable analyses on life course trajectories on risk factors of non-communicable diseases
Explore different life course models
Fig. 3  Main concepts of the LifeCycle Project and related data in the EU Child Cohort Network
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Accessible
A harmonized set of data for EU Child Cohort Network is 
available by a server controlled by or located at each spe-
cific institute. Harmonized data from each cohort are held 
on secure Opal servers (http://opald oc.obiba .org/en/lates 
t/) at their institution. Protocols for setting up this data 
infrastructure are available, together with YouTube instruc-
tion videos. Data are accessed via a central analysis server 
using the R-based platform DataSHIELD. Access to data 
is conditional on approval by the cohort. Partners and their 
cohorts can always decide to share research data without 
using DataSHIELD, conditional on relevant local ethical and 
legal approvals. This approach is used for analyses that are 
not yet possible in DataSHIELD [25]. The field of data shar-
ing and cross study analyses is rapidly advancing. Although 
we start with using DataSHIELD, we recognise that over 
time this may change.
Interoperable
Existing data have been harmonized and integrated into 
exposure variables to make them interoperable. Protocols 
for harmonization are available online. All harmonized data 
from different cohorts have been renamed into standardized 
variable names. A full list of the available variables per 
cohort is available in the EU Child Cohort Network Vari-
able Catalogue.
Reusable
The EU Child Cohort Network reuses data that are already 
available within cohorts. The EU Child Cohort Network, with 
the harmonized set of variables and infrastructure, should be 
sustainable beyond the duration of the LifeCycle Project. Dur-
ing the last two years, four other European consortia have been 
funded, which are planning to build upon the harmonized data 
and federated analysis infrastructure in the EU Child Cohort 
Network. These consortia include the EUCAN-Connect, 
NutriPROGRAM, ATHLETE and LongITools Projects. 
Future collaborations may include not only European, but also 
global initiatives such as the NIH-Environmental influences 
on Child Health Outcomes (ECHO) Programme in the United 
States, which aims to build a virtual paediatric cohort based 
on new and existing birth cohorts, recognizing the enormous 
Fig. 4  Federated analysis approach using DataSHIELD approach
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opportunities in optimizing and networking existing resources 
[43, 44].
Data governance
The LifeCycle Project or EU Child Cohort Network do not 
own data, but bring data from other cohorts together via a 
federated data analysis platform. Ethical and legal respon-
sibility for data management and security is maintained 
by the source studies or home institutions. The principal 
investigators or home institutions should always administer 
permission for external access to specific data on their server 
for addressing research questions. The EU Child Cohort Net-
work cannot provide open access to researchers. The data 
sharing protocols and agreements will be updated regularly, 
according to new legal practices, such as the European 
General Data Protection Regulation 2016/679 (GDPR). All 
governance protocols will take not only the short-term, but 
also the long-term EU Child Cohort Network, beyond the 
LifeCycle Project duration, into account.
 EU Child Cohort Network research proposals
Proposals for research using the EU Child Cohort Network 
can be put forward by both LifeCycle Project partners and 
other researchers. External researchers can send a request 
for EU Child Cohort Network data use to the participating 
cohorts or lifecycle@erasmusmc.nl. Each LifeCycle Pro-
ject proposal is discussed in the relevant coordinating work 
package (https ://lifec ycle-proje ct.eu/for-scien tists /workp 
ackag es/) and subsequently distributed among all cohorts 
participating in the LifeCycle Project and EU Child Cohort 
Network. Cohorts can opt-in or opt-out of each analysis, 
depending on the data availability, research interests or 
involvement in other projects. In the first phase, the focus of 
research projects is on those projects related to the LifeCycle 
Project research aims (see below). An efficient governance 
structure was organized and agreed upon by researchers 
and ethical and legal representatives. EU Child Cohort Net-
work governance structure will be updated regularly where 
needed and will be made sustainable after the LifeCycle 
Project duration. Because there is no physical transfer of 
data needed, we are currently exploring the possibility of 
working with a short Data Access Agreement that replaces 
commonly used Data Transfer Agreements. When the EU 
Child Cohort Network is fully operational we aim to have 
regular EU Child Cohort Network meetings or telephone 
conferences to discuss:
• Research projects (novel proposals, progress of ongoing 
projects);
• Harmonization (novel proposals, progress of ongoing 
efforts);
• DataSHIELD analysis approaches (priorities for further 
development);
• Any relevant ethical or legal issues concerning federated 
analysis approaches;
Participants in these meetings or telephone conferences 
are not only LifeCycle Project Partners, but representatives 
of all institutes that have harmonized their data and set up 
the IT infrastructure needed for the federated analysis of 
data via DataShield.
LifeCycle Project primary research areas
The LifeCycle Project uses the integrated and harmonized 
set of variables from the EU Child Cohort Network for iden-
tification of early-life stressors influencing cardio-metabolic, 
respiratory and mental developmental adaptations and health 
trajectories during the full life course (Fig. 3).
Integrated early‑life stressors approach 
and the exposome
Early-life stressors, including socio-economic, migration, 
urban environmental, and lifestyle related factors, have been 
associated with cardio-metabolic, respiratory, and mental 
Table 3  Websites of the LifeCycle Project–EU child cohort network
Data related to the LifeCycle Project is findable through different 
websites
LifeCyce Project
https ://lifec ycle-proje ct.eu website
Overview of the LifeCycle Project
All protocols for harmonisation and setting up the data-servers
Open access
Links to other relevant websites
Birthcohorts.net
www.birth cohor ts.net
Overview of all cohorts and their data
Open access, no restriction for access on cohort information
EU Child Cohort Network Variable Catalogue
http://catal ogue.lifec ycle-proje ct.eu
Overview of harmonized data and variables in each cohort
Open access
Find function is included in website
EU Child Cohort harmonized data
Cohort websites via www.lifec ycle-proje ct.eu
Harmonized data from different cohorts
Data server is within institutional firewall
Access to data can only be given by data owner (LifeCycle Project 
partner)
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health and disease, which together contribute greatly to the 
global burden of non-communicable diseases [5–22]. An 
accumulating body of evidence suggests that exposure to 
these factors during fetal life and childhood affects later 
life health trajectories [38]. Thus far, studies focused on the 
effects of early-life environmental exposures on later life 
health outcomes have largely been using a ‘one-exposure at 
one-time point’ approach. Research from LifeCycle Project 
partners suggests that instead of exposure to single stress-
ors that individually may have weak effects, exposure to a 
cluster or pattern of adverse early-life stressors in specific 
age windows is more likely to influence health during the 
lifecycle [39]. We will apply a holistic ‘early-life exposome’ 
model to encompass many human environmental exposures, 
which is dynamic from conception onwards and comple-
ments the genome. To develop this early-life exposome, 
we will specifically take into account measurements in the 
external environment (socio-economic, migration, urban 
environment, and lifestyle factors), and biological mark-
ers reflecting the internal environment (DNA methylation, 
RNA expression, and metabolomics), and the dynamic life 
course nature of the exposome. We will use available meth-
ods developed as part of the EU-FP7 HELIX Project for 
further development of the early-life exposome model [29].
Cardio‑metabolic, respiratory and mental health 
outcomes
Embryonic life, fetal life and early childhood are charac-
terized by high developmental rates and seem to be criti-
cal periods for developmental adaptations with long-term 
consequences. Research from LifeCycle Project partners 
have shown that specific maternal lifestyle factors and fetal 
growth variation in early pregnancy are related to non-com-
municable diseases and their risk factors [45–49]. We will 
use repeatedly measured exposure, mediator and outcome 
data from the EU Child Cohort Network to compare differ-
ent potential life course models including those assuming 
specific critical periods and those assuming interactive and 
cumulative effects throughout the life course. We will relate 
early-life stressors measured in different early-life periods 
(preconception, fetal life, early childhood) with life course 
health trajectories. We specifically hypothesize that early-life 
stressors lead to developmental adaptations of:
• The cardiovascular system assessed in detail by advanced 
cardiac and great vessel ultrasound or Magnetic Reso-
nance Imaging (MRI), and systemic metabolism, 
detected by measuring hundreds of metabolites using 
high-throughput approaches, which precede the devel-
opment of cardio-metabolic diseases [50–60].
• Lung volumes, airway patency assessed by lung function 
measurements and clinical assessments, and immuno-
logical or allergy-related assessments, which precede the 
development of respiratory disease [61–63].
• Structural and functional brain development assessed by 
ultrasound in fetal life or early infancy, or brain MRI 
in later life, which precede the development of mental 
health outcomes [64–67].
Epigenetic pathways
An accumulating body of evidence suggests that epigenetic 
changes play a key role in the associations of early-life 
stressors with lifecycle health and disease trajectories [68]. 
DNA methylation, the most frequently studied epigenetic 
phenomenon in large populations, is a dynamic process, 
which may be influenced by environmental stressors such 
urban environment, dietary factors and smoking [68]. DNA 
methylation changes are more common in early life. LifeCy-
cle Project partners have identified DNA methylation mark-
ers related to specific early-life stressors including maternal 
BMI, smoking, dietary factors and birth weight [12, 17]. The 
EU Child Cohort Network brings together many pregnancy 
and childhood cohorts with information about epigenome-
wide DNA methylation. Availability of repeatedly measured 
DNA methylation and of RNA expression data enables stud-
ies on persistence and functionality of DNA methylation 
markers potentially involved in early-life programming of 
non-communicable diseases.
Population impact
The concept that early life is critical for health and disease 
throughout the life course is well-acknowledged. However, 
there is still not much evidence for effective prevention or 
intervention strategies using early life as a window of oppor-
tunity to maximize the human developmental potential dur-
ing the full life course. We will use different approaches to 
translate findings into population health recommendations. 
These include causal inference, aggregation of evidence for 
interventions based on reviews, dynamic microsimulation, 
and development of prediction models.
Causality cannot be directly concluded from observa-
tional studies. Advanced analytical approaches that can help 
to infer causality include sibling comparison studies, propen-
sity score matching and Mendelian randomization studies, in 
which genetic variants are used as unconfounded proxies for 
adverse exposures [69]. The EU Child Cohort Network facil-
itates integration of different causal inference methods and 
comparison of their findings, which will strengthen causal 
inference needed for translation of findings from observa-
tional studies to public health recommendations.
We will review and summarize evidence based on find-
ings both from observational studies in the EU Child Cohort 
Network and from published intervention studies to develop 
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recommendations for population and subgroup-specific 
interventions focused on the earliest phases of life. Dynamic 
microsimulation modelling using data from cohort studies 
enables policy evaluations and scenario analyses focused on 
early-life interventions when experimental studies are not 
possible [70, 71]. The EU Child Cohort Network provides 
a unique infrastructure for these analyses, because of the 
available data and variation in exposures and outcomes, life 
course trajectories of non-communicable diseases and vari-
ous subpopulations with different baseline risks.
Data from observational studies can help to develop  mod-
els to predict risk factors for non-communicable diseases. 
Previous studies suggested that pregnancy, birth and infancy 
characteristics have the potential to identify groups at risk 
for obesity [72, 73]. The EU Child Cohort Network is the 
ideal platform to develop models to predict from early-life 
stressor data the onset of risk factors for cardio-metabolic, 
respiratory and mental disease across the lifecycle. Models 
can include various background characteristics, which ena-
ble baseline risk estimation from socio-economic, migration, 
environment and lifestyle stressors, which may be difficult 
to modify in the short-term but help to predict the outcomes 
of interest.
Finally, we will develop E-learning modules and eHealth 
applications that will be made widely available to make the 
knowledge and research findings available for educational 
and health care purposes.
Conclusion
The LifeCycle Project and its EU Child Cohort Network lead 
to great opportunities for researchers to combine harmonized 
data from different cohorts by a federated analysis platform. 
It also provides a novel model for collaborative research in 
large research infrastructures with individual level data. The 
LifeCycle Project will translate results from research using 
the EU Child Cohort Network into recommendations for 
targeted prevention strategies to improve health trajectories 
for current and future generations by optimizing their earli-
est phases of life.
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